Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases

INTRODUCTION: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, correlates with cardiovascular risk especially in patients with chronic kidney disease. The aim of our study was to establish significance of ADMA as a biomarker of arterial damage in children with gl...

Descripción completa

Detalles Bibliográficos
Autores principales: SKRZYPCZYK, PIOTR, PRZYCHODZIEŃ, JOANNA, MIZERSKA-WASIAK, MAŁGORZATA, KUŹMA-MROCZKOWSKA, ELŻBIETA, STELMASZCZYK-EMMEL, ANNA, GóRSKA, ELŻBIETA, PAŃCZYK-TOMASZEWSKA, MAŁGORZATA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Clinical Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050061/
https://www.ncbi.nlm.nih.gov/pubmed/32140048
http://dx.doi.org/10.5114/ceji.2019.92788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050061/
https://www.ncbi.nlm.nih.gov/pubmed/32140048
http://dx.doi.org/10.5114/ceji.2019.92788

Ejemplares similares